switzerlanden
Size and Value in China

Size and Value in China

06-12-2018 | From the field

Factor investing in A-share markets? This paper1 shows that the two classic Fama-French factors, size and value, are also powerful predictors of stock returns in China. To get the most out of these factors, the authors propose to tweak the definitions a bit.

  • David Blitz
    David
    Blitz
    Chief Researcher

For the size factor they exclude the 30% smallest firms, which they justify by arguing that these companies are valued significantly as potential shells in reverse mergers that circumvent tight IPO constraints. Their preferred value factor for China is the earnings-price ratio, which they find subsumes the book-to-market ratio that is typically used in academia.

The study shows that a three-factor model constructed in this way strongly dominates the standard Fama-French approach in China. As practitioners we prefer to use a diversified mix of value factors that work consistently across different markets, rather than trying to identify the one best metric.

The issue of reverse mergers, or backdoor listings, is one of the reasons why for our quantitative strategies we conduct more thorough fundamental screening of stocks listed in China to define a clean investable universe. 

1Liu, Stambaugh & Yuan, “Size and Value in China”, NBER Working Paper No. w24458, 2018.

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subscribe
From the field
From the field

Our researchers publish many whitepapers based on their own empirical studies; they also follow quantitative research done by others.

Read all articles
Subjects related to this article are:
Logo

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree